Similar articles

• Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

  Folprecht G, Köhne CH, Lutz MP. Folprecht G, et al. Cancer Treat Res. 2007;134:425-40. doi: 10.1007/978-0-387-48993-3_28. Cancer Treat Res. 2007. PMID: 17633071 Review. No abstract available.
• [Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy].

  Legendre H, Delaunoit T, Chassaing C, Pector JC. Legendre H, et al. Rev Med Brux. 2005 Sep-Oct;26(5):439-44. Rev Med Brux. 2005. PMID: 16318097 Review. French.
• Chemotherapy treatment of chyloperitoneum and peritoneal carcinomatosis due to cervical cancer--review of literature.

  Keung YK, Whitehead RP, Cobos E. Keung YK, et al. Gynecol Oncol. 1996 Jun;61(3):448-50. doi: 10.1006/gyno.1996.0173. Gynecol Oncol. 1996. PMID: 8641632 Review.
• Discussion.

  [No authors listed] [No authors listed] J Am Coll Surg. 2014 Apr;218(4):586-7. doi: 10.1016/j.jamcollsurg.2014.01.010. J Am Coll Surg. 2014. PMID: 24655844 No abstract available.
• Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer.

  Roviello F, Pinto E, Corso G, Pedrazzani C, Caruso S, Filippeschi M, Petrioli R, Marsili S, Mazzei MA, Marrelli D. Roviello F, et al. J Surg Oncol. 2010 Nov 1;102(6):663-70. doi: 10.1002/jso.21682. J Surg Oncol. 2010. PMID: 20721959